BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36052238)

  • 1. Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy.
    Yang Z; Wu Z; Xiong Y; Liu S; Cai C; Shao Z; Zhu Y; Song X; Shen W; Wang X; Wu X; Gong W
    Front Oncol; 2022; 12():977963. PubMed ID: 36052238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Response to Gemcitabine, Cisplatin, and Nab-Paclitaxel Followed by Maintenance Therapy for Advanced Gallbladder Cancer: A Case Report and Literature Review.
    Liu T; Li Q; Zhang W; Zhu Q
    Front Oncol; 2021; 11():733955. PubMed ID: 34676166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nab-paclitaxel: An effective third-line chemotherapy in patients with advanced, unresectable gallbladder cancer.
    Talwar V; Raina S; Goel V; Dash P; Doval DC
    Indian J Med Res; 2020 Nov; 152(5):475-481. PubMed ID: 33707389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced pancreatic cancer successfully treated by distal pancreatectomy with celiac axis resection (DP-CAR) after S-1 with radiation therapy followed by gemcitabine/nab-paclitaxel therapy: a case report.
    Ariake K; Motoi F; Mizuma M; Murakami K; Takadate T; Ohtsuka H; Fukase K; Masuda K; Hayashi H; Nakagawa K; Sakata N; Morikawa T; Maeda S; Naitoh T; Egawa S; Unno M
    Surg Case Rep; 2017 Dec; 3(1):15. PubMed ID: 28101795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer.
    Zhang S; Nie J; Tai S; Zheng T
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38123314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer.
    Kunzmann V; Herrmann K; Bluemel C; Kapp M; Hartlapp I; Steger U
    Case Rep Oncol; 2014 Sep; 7(3):648-55. PubMed ID: 25408659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancer.
    Lu C; Zhu Y; Kong W; Yang J; Zhu L; Wang L; Tang M; Chen J; Li Q; He J; Li A; Qiu X; Gu Q; Chen D; Meng F; Liu B; Qiu Y; Du J
    Front Oncol; 2022; 12():879661. PubMed ID: 36059628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1 inhibitors plus nab-paclitaxel-containing chemotherapy for advanced gallbladder cancer in a second-line setting: A retrospective analysis of a case series.
    Tan S; Yu J; Huang Q; Zhou N; Gou H
    Front Oncol; 2022; 12():1006075. PubMed ID: 36465365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report.
    Miura Y; Ashida R; Sugiura T; Ohgi K; Yamada M; Otsuka S; Todaka A; Uesaka K
    Surg Case Rep; 2022 Jan; 8(1):20. PubMed ID: 35079922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion surgery with gemcitabine plus nab-paclitaxel for locally advanced unresectable pancreatic cancer: A case report.
    Okura R; Takano S; Yokota T; Yoshitomi H; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Nojima H; Mishima T; Miyazaki M; Ohtsuka M
    Mol Clin Oncol; 2018 Oct; 9(4):389-393. PubMed ID: 30214727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Conversion Surgery Following Chemotherapy in Initially Unresectable Locally Advanced Gallbladder Carcinoma].
    Hashimoto Y; Ueno K; Akita M; Tsugawa D; Awazu M; Mukubou H; Komatsu S; Terai S; Tanaka M; Kido M; Toyama H; Ajiki T; Fukumoto T
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):775-777. PubMed ID: 31164532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic artery transposition for hepatic arterial reconstruction in conversion surgery of an initially unresectable, locally advanced pancreatic cancer after gemcitabine/nab-paclitaxel: A case report.
    Tanaka H; Imai H; Higashi T; Murase K; Matsuhashi N; Yoshida K
    Int J Surg Case Rep; 2021 Jan; 78():192-196. PubMed ID: 33360334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer.
    Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D
    BMC Cancer; 2021 Aug; 21(1):936. PubMed ID: 34412605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally advanced gallbladder cancer: a review of the criteria and role of imaging.
    Gupta P; Meghashyam K; Marodia Y; Gupta V; Basher R; Das CK; Yadav TD; Irrinki S; Nada R; Dutta U
    Abdom Radiol (NY); 2021 Mar; 46(3):998-1007. PubMed ID: 32945922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer.
    Woo SM; Lee SH; Yoo JW; Yang KY; Seo JG; Park JK; Hwang JH; Lee WJ; Ryu JK; Kim YT; Yoon YB
    Gut Liver; 2013 Sep; 7(5):594-8. PubMed ID: 24073318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report.
    Wakasa Y; Toyoki Y; Kusumi T; Kameyama Y; Odagiri T; Jin H; Nakai M; Aoki K; Kawashima H; Endo M
    Surg Case Rep; 2022 Mar; 8(1):50. PubMed ID: 35332404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plus nab-paclitaxel chemotherapy: A case report.
    Yokota T; Takano S; Yoshitomi H; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Suzuki D; Sakai N; Nojima H; Mishima T; Nakadai E; Ohtsuka M
    Mol Clin Oncol; 2019 Apr; 10(4):419-424. PubMed ID: 30931110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing the incidentally detected gallbladder cancer: algorithms and controversies.
    Cavallaro A; Piccolo G; Di Vita M; Zanghì A; Cardì F; Di Mattia P; Barbera G; Borzì L; Panebianco V; Di Carlo I; Cavallaro M; Cappellani A
    Int J Surg; 2014; 12 Suppl 2():S108-S119. PubMed ID: 25182380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer.
    Sirohi B; Mitra A; Jagannath P; Singh A; Ramadvar M; Kulkarni S; Goel M; Shrikhande SV
    Future Oncol; 2015; 11(10):1501-9. PubMed ID: 25963427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding.
    Cavallaro A; Piccolo G; Panebianco V; Lo Menzo E; Berretta M; Zanghì A; Di Vita M; Cappellani A
    World J Gastroenterol; 2012 Aug; 18(30):4019-27. PubMed ID: 22912553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.